Literature DB >> 10820173

High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation.

Marie-Claude Monier-Faugere1, Hanna Mawad1, Quanle Qi1, Robert M Friedler1, Hartmut H Malluche1.   

Abstract

Kidney transplantation corrects most of the metabolic abnormalities that cause renal osteodystrophy. However, many transplanted patients develop osteoporosis and other bone lesions that are related, at least in part, to their immunosuppressive regimen. The precise histologic patterns of bone disease after transplantation are not well defined. In a study designed to investigate this issue, 57 adult posttransplant patients agreed to undergo bone biopsies and blood drawings. There were 32 men and 25 women, mean age 45 +/- 2 yr, who had received a kidney transplantation 5.6 +/- 0.8 yr before biopsy. History of bone pain, fractures, and avascular necrosis was found in 22, 12, and 7 patients, respectively. Serum creatinine was 1.68 +/- 0.1 mg/dl, 21% of patients were hypercalcemic, 63.2% had elevated parathyroid hormone (PTH) (>65 pg/ml), and 91.2% had normal calcitriol levels. Cancellous bone volume/tissue volume was below normal compared to age- and gender-matched control subjects in 56.1% of patients. Bone turnover (activation frequency) was low in 45.6%, normal in 28.1%, and elevated in 26.3% of patients. Bone formation rate/bone surface was low in 59.7%, normal in 35%, and elevated in 5. 3% of the patients. Erosion surface/bone surface was high in 21.1% of patients. Mineralization was prolonged in 87.5% of patients, including 9 patients with osteomalacia and 12 patients with focal osteomalacia. Cumulative and maintenance doses of prednisone and time elapsed since transplantation correlated negatively with bone volume and bone turnover (r = -0.32 to -0.59, P < 0.05 to 0.01), whereas cumulative doses of cyclosporine or azathioprine, age, gender, or serum PTH levels did not. Regression analysis identified prednisone as the main factor responsible for low bone volume and bone turnover (r = 0.54 and r = 0.43, P < 0.01). No factors were found to predict delayed mineralization. The present study shows that low bone volume, low bone turnover, and generalized or focal osteomalacia are frequent histologic features in transplanted patients. The effects of age, gender, PTH, and cyclosporine on bone volume and bone turnover are apparently overridden by the prominent effects of glucocorticoids. The prevalence of mineralization defect in the presence of normal serum levels of calcidiol and calcitriol suggests vitamin D resistance and deserves further study.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10820173     DOI: 10.1681/ASN.V1161093

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  45 in total

1.  Correction of metabolic acidosis with potassium citrate in renal transplant patients and its effect on bone quality.

Authors:  Astrid Starke; Alf Corsenca; Thomas Kohler; Johannes Knubben; Marius Kraenzlin; Daniel Uebelhart; Rudolf P Wüthrich; Brigitte von Rechenberg; Ralph Müller; Patrice M Ambühl
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-05       Impact factor: 8.237

Review 2.  Bone Disease after Kidney Transplantation.

Authors:  Antoine Bouquegneau; Syrazah Salam; Pierre Delanaye; Richard Eastell; Arif Khwaja
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-15       Impact factor: 8.237

Review 3.  Mineral and bone disorders in kidney transplant recipients: reversible, irreversible, and de novo abnormalities.

Authors:  Takashi Hirukawa; Takatoshi Kakuta; Michio Nakamura; Masafumi Fukagawa
Journal:  Clin Exp Nephrol       Date:  2015-05-02       Impact factor: 2.801

Review 4.  Metabolic bone diseases in kidney transplant recipients.

Authors:  Rubin Zhang; Kanwaljit K Chouhan
Journal:  World J Nephrol       Date:  2012-10-06

5.  Comparison of calcium and alfacalcidol supplement in the prevention of osteopenia after kidney transplantation.

Authors:  C Berczi; L Asztalos; Z Kincses; A Balogh; L Löcsey; G Balázs; G Lukács
Journal:  Osteoporos Int       Date:  2003-04-16       Impact factor: 4.507

6.  Bone mineral density in live related kidney transplant children and adolescents.

Authors:  Amr A el-Husseini; Amgad E el-Agroudy; Ehab W Wafa; Tarek Mohsen; Mohamed A Sobh; Mohamed A Ghoneim
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

7.  Individualized therapy to prevent bone mineral density loss after kidney and kidney-pancreas transplantation.

Authors:  Rahul Mainra; Grahame J Elder
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 8.237

Review 8.  Post-renal transplantation hypophosphatemia.

Authors:  Khashayar Sakhaee
Journal:  Pediatr Nephrol       Date:  2009-07-15       Impact factor: 3.714

Review 9.  Bone and mineral disorders after kidney transplantation: therapeutic strategies.

Authors:  Miklos Z Molnar; Mohamed S Naser; Connie M Rhee; Kamyar Kalantar-Zadeh; Suphamai Bunnapradist
Journal:  Transplant Rev (Orlando)       Date:  2013-12-12       Impact factor: 3.943

10.  Long-term fracture risk following renal transplantation: a population-based study.

Authors:  Line M Vautour; L Joseph Melton; Bart L Clarke; Sara J Achenbach; Ann L Oberg; James T McCarthy
Journal:  Osteoporos Int       Date:  2003-12-09       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.